Imaging HER2-positive metastatic esophagogastric cancer with 89Zr-trastuzumab PET and 18F-FDG PET.

Melissa Lumish,Steven Brad Maron,Viktoriya Paroder,Steven Philemond,Joseph A. O' Donoghue,Heiko Schöder,Jason S. Lewis,Yelena Y. Janjigian,Neeta Pandit-Taskar

Journal of Clinical Oncology（2021）

引用 1|浏览5

暂无评分

摘要

4068Background: Variations in HER2 expression between primary tumor and metastases may contribute to drug resistance in HER2-positive mEG cancer. Whole body imaging with 89Zr-trastuzumab PET has a ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要